Coronavirus disease 2019 has disrupted oncologic care across the spectrum of cancer screening, diagnosis, and management.
Aakash Desai, MBBS, MPH
Advertisement
Articles by Aakash Desai, MBBS, MPH
Advertisement
Latest Updated Articles
COVID-19 and Its Impact on Oncology Clinical TrialsPublished: March 19th 2021 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
